These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 8854470)

  • 1. [Physiotherapy in chronic obstructive pulmonary disease: oscillatory breathing with flutter VRP1].
    Weiner P; Zamir D; Waizman J; Weiner M
    Harefuah; 1996 Jul; 131(1-2):14-7, 71. PubMed ID: 8854470
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Efficacy of the FLUTTER VRP1 device for physiotherapy patients with chronic pulmonary disease].
    Lubiński W; Targowski T; Frank-Piskorska A
    Pol Merkur Lekarski; 2000 Jan; 7(43):37-40. PubMed ID: 10765651
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Physical therapy in patients with COPD and tracheobronchial instability--comparison of 2 oscillating PEP systems (RC-Cornet, VRP1 Desitin). Results of a randommized prospective study of 90 patients].
    Cegla UH; Bautz M; Fröde G; Werner T
    Pneumologie; 1997 Feb; 51(2):129-36. PubMed ID: 9157451
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Physical therapy with VRP1 in chronic obstructive respiratory tract diseases--results of a multicenter comparative study].
    Cegla UH; Retzow A
    Pneumologie; 1993 Nov; 47(11):636-9. PubMed ID: 8309924
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Physiotherapy with oscillating PEP systems (RC-Cornet, VRP1) in COPD].
    Cegla UH
    Pneumologie; 2000 Oct; 54(10):440-6. PubMed ID: 11089396
    [No Abstract]   [Full Text] [Related]  

  • 6. [Acute effect of use of the Flutter on expectoration of sputum in patients with chronic respiratory diseases].
    Nakamura S; Kawakami M
    Nihon Kyobu Shikkan Gakkai Zasshi; 1996 Feb; 34(2):180-5. PubMed ID: 8622274
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mechanical vibration and conventional chest physiotherapy in outpatients with stable chronic obstructive lung disease.
    Mohsenifar Z; Rosenberg N; Goldberg HS; Koerner SK
    Chest; 1985 Apr; 87(4):483-5. PubMed ID: 3884288
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sputum rheology changes in cystic fibrosis lung disease following two different types of physiotherapy: flutter vs autogenic drainage.
    App EM; Kieselmann R; Reinhardt D; Lindemann H; Dasgupta B; King M; Brand P
    Chest; 1998 Jul; 114(1):171-7. PubMed ID: 9674466
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effectiveness of erdosteine in elderly patients with bronchiectasis and hypersecretion: a 15-day, prospective, parallel, open-label, pilot study.
    Crisafulli E; Coletti O; Costi S; Zanasi E; Lorenzi C; Lucic S; Fabbri LM; Bertini M; Clini EM
    Clin Ther; 2007 Sep; 29(9):2001-9. PubMed ID: 18035199
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Flutter VRP1 as an adjunct to chest physiotherapy in cystic fibrosis.
    Pryor JA; Webber BA; Hodson ME; Warner JO
    Respir Med; 1994 Oct; 88(9):677-81. PubMed ID: 7809441
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mechanical evaluation of a respiratory device.
    de Lima LC; Duarte JB; Lépore Neto FP; Abe PT; Gastaldi AC
    Med Eng Phys; 2005 Mar; 27(2):181-7. PubMed ID: 15642514
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Flutter VRP1: a new personal pocket therapeutic device used as an adjunct to drug therapy in the management of bronchial asthma.
    Girard JP; Terki N
    J Investig Allergol Clin Immunol; 1994; 4(1):23-7. PubMed ID: 8081537
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Noninvasive clearance of airway secretions.
    Hardy KA; Anderson BD
    Respir Care Clin N Am; 1996 Jun; 2(2):323-45. PubMed ID: 9390886
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Respiratory physiotherapy and respiratory mechanics of chronic respiratory insufficiency].
    Housset B; Tetard C; Derenne JP
    Rev Fr Mal Respir; 1983; 11(6):915-21. PubMed ID: 6366946
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Flutter-VRP1 Desitin--a new physiotherapeutic device for the treatment of chronic obstructive bronchitis.
    Leru P; Bistriceanu G; Ibraim E; Stoicescu P
    Rom J Intern Med; 1994; 32(4):315-20. PubMed ID: 7613505
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oscillatory Positive Expiratory Pressure in Chronic Obstructive Pulmonary Disease.
    Svenningsen S; Paulin GA; Sheikh K; Guo F; Hasany A; Kirby M; Rezai RE; McCormack DG; Parraga G
    COPD; 2016; 13(1):66-74. PubMed ID: 26430763
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of an Airway Clearance Device on Inflammation, Bacteriology, and Mucus Transport in Bronchiectasis.
    Tambascio J; de Souza HCD; Martinez R; Baddini-Martinez JA; Barnes PJ; Gastaldi AC
    Respir Care; 2017 Aug; 62(8):1067-1074. PubMed ID: 28733314
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical characteristics, respiratory functional parameters, and outcome of a two-hour T-piece trial in patients weaning from mechanical ventilation.
    Vallverdú I; Calaf N; Subirana M; Net A; Benito S; Mancebo J
    Am J Respir Crit Care Med; 1998 Dec; 158(6):1855-62. PubMed ID: 9847278
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association of chronic mucus hypersecretion with FEV1 decline and chronic obstructive pulmonary disease morbidity. Copenhagen City Heart Study Group.
    Vestbo J; Prescott E; Lange P
    Am J Respir Crit Care Med; 1996 May; 153(5):1530-5. PubMed ID: 8630597
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Occurrence of respiratory symptoms in persons with restrictive ventilatory impairment compared with persons with chronic obstructive pulmonary disease: The PLATINO study.
    Nonato NL; Nascimento OA; Padilla RP; de Oca MM; Tálamo C; Valdivia G; Lisboa C; López MV; Celli B; Menezes AM; Jardim JR
    Chron Respir Dis; 2015 Aug; 12(3):264-73. PubMed ID: 26041119
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.